Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
about
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patientsCIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer.Antibodies against annexin A5: detection pitfalls and clinical associations.Antitumor activity of pluripotent cell-engineered vaccines and their potential to treat lung cancer in relation to different levels of irradiationCIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma.Current Status and Prospective Regarding the Therapeutic Potential of Natural Autoantibodies in Cancer Therapy.
P2860
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@ast
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@en
type
label
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@ast
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@en
prefLabel
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@ast
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@en
P2093
P1433
P1476
Autoimmunization to epidermal growth factor, a component of the immunological homunculus.
@en
P2093
P356
10.1016/S1568-9972(01)00015-5
P577
2002-02-01T00:00:00Z